Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Translational dysregulation by Pateamine A.

Korneeva NL.

Chem Biol. 2007 Jan;14(1):5-7.

2.

RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.

Bordeleau ME, Cencic R, Lindqvist L, Oberer M, Northcote P, Wagner G, Pelletier J.

Chem Biol. 2006 Dec;13(12):1287-95.

4.

Stopping trouble before it starts.

Clardy J.

ACS Chem Biol. 2006 Feb 17;1(1):17-9.

PMID:
17163634
5.

Inhibition of eukaryotic translation initiation by the marine natural product pateamine A.

Low WK, Dang Y, Schneider-Poetsch T, Shi Z, Choi NS, Merrick WC, Romo D, Liu JO.

Mol Cell. 2005 Dec 9;20(5):709-22.

6.

Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.

Bordeleau ME, Matthews J, Wojnar JM, Lindqvist L, Novac O, Jankowsky E, Sonenberg N, Northcote P, Teesdale-Spittle P, Pelletier J.

Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10460-5. Epub 2005 Jul 19.

7.

Differential action of pateamine A on translation of genomic and subgenomic mRNAs from Sindbis virus.

González-Almela E, Sanz MA, García-Moreno M, Northcote P, Pelletier J, Carrasco L.

Virology. 2015 Oct;484:41-50. doi: 10.1016/j.virol.2015.05.002. Epub 2015 Jun 5.

8.

Inhibition of nonsense-mediated mRNA decay by the natural product pateamine A through eukaryotic initiation factor 4AIII.

Dang Y, Low WK, Xu J, Gehring NH, Dietz HC, Romo D, Liu JO.

J Biol Chem. 2009 Aug 28;284(35):23613-21. doi: 10.1074/jbc.M109.009985. Epub 2009 Jul 1.

9.

Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine A.

Low WK, Dang Y, Schneider-Poetsch T, Shi Z, Choi NS, Rzasa RM, Shea HA, Li S, Park K, Ma G, Romo D, Liu JO.

Methods Enzymol. 2007;431:303-24. Review.

PMID:
17923240
10.

Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A.

Dang Y, Kedersha N, Low WK, Romo D, Gorospe M, Kaufman R, Anderson P, Liu JO.

J Biol Chem. 2006 Oct 27;281(43):32870-8. Epub 2006 Sep 2.

11.

Inhibitors of translation targeting eukaryotic translation initiation factor 4A.

Cencic R, Galicia-Vázquez G, Pelletier J.

Methods Enzymol. 2012;511:437-61. doi: 10.1016/B978-0-12-396546-2.00020-6.

PMID:
22713332
12.

Inhibitors of translation initiation as cancer therapeutics.

Lindqvist L, Pelletier J.

Future Med Chem. 2009 Dec;1(9):1709-22. doi: 10.4155/fmc.09.122. Review.

PMID:
21425987
13.

Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence.

Raza F, Waldron JA, Quesne JL.

Biochem Soc Trans. 2015 Dec;43(6):1227-33. doi: 10.1042/BST20150163. Review.

PMID:
26614665
14.

Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.

Iwasaki S, Floor SN, Ingolia NT.

Nature. 2016 Jun 23;534(7608):558-61. doi: 10.1038/nature17978. Epub 2016 Jun 15.

15.

HuD stimulates translation via eIF4A.

Chen CY, Shyu AB.

Mol Cell. 2009 Dec 25;36(6):920-1. doi: 10.1016/j.molcel.2009.12.013.

16.

Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents.

Low WK, Li J, Zhu M, Kommaraju SS, Shah-Mittal J, Hull K, Liu JO, Romo D.

Bioorg Med Chem. 2014 Jan 1;22(1):116-25. doi: 10.1016/j.bmc.2013.11.046. Epub 2013 Dec 4.

17.

Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA.

Dobrikov MI, Shveygert M, Brown MC, Gromeier M.

Mol Cell Biol. 2014 Feb;34(3):439-51. doi: 10.1128/MCB.01046-13. Epub 2013 Nov 18.

18.

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH.

Mol Cell Biol. 2003 Jan;23(1):26-37.

19.

Characterizing mRNA interactions with RNA granules during translation initiation inhibition.

Zurla C, Lifland AW, Santangelo PJ.

PLoS One. 2011 May 5;6(5):e19727. doi: 10.1371/journal.pone.0019727.

20.

Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A.

Kuznetsov G, Xu Q, Rudolph-Owen L, Tendyke K, Liu J, Towle M, Zhao N, Marsh J, Agoulnik S, Twine N, Parent L, Chen Z, Shie JL, Jiang Y, Zhang H, Du H, Boivin R, Wang Y, Romo D, Littlefield BA.

Mol Cancer Ther. 2009 May;8(5):1250-60. doi: 10.1158/1535-7163.MCT-08-1026. Epub 2009 May 5.

Supplemental Content

Support Center